Robotic versus open primary ventral hernia repair: A randomized controlled trial (Robovent Trial).

Da Vinci DaVinci Epigastric hernia Hernia repair Laparotomy Mesh PVHR Repair Robot Technique Trial Umbilical hernia Ventral hernia

Journal

International journal of surgery protocols
ISSN: 2468-3574
Titre abrégé: Int J Surg Protoc
Pays: England
ID NLM: 101758186

Informations de publication

Date de publication:
2020
Historique:
received: 27 01 2020
revised: 23 03 2020
accepted: 24 03 2020
entrez: 6 5 2020
pubmed: 6 5 2020
medline: 6 5 2020
Statut: epublish

Résumé

The objective of the present study is to compare the outcomes open PVHR and robotic PVHR. The present study will be a randomized single-blinded controlled trial with intention-to-treat analysis comparing robotic PVHR to open PVHR in adult patients undergoing elective PVHR with a defect ranging between 1-5 cm. Patient refusing to participate, not able to give informed consent, with history of intra-abdominal surgery contraindicating a robotic surgical approach will be excluded. The intervention will consist in laparoscopic robotically assisted trans-abdominal pre-peritoneal epigastric or umbilical PVHR with closure of fascial defect and non-adsorbable mesh reinforcement. The control will be open pre-peritoneal epigastric or umbilical hernia repair with closure of fascial defect and non-absorbable mesh reinforcement. The primary outcome will be the incidence of wound-related complication within 1 month. The secondary outcomes will be esthetic satisfaction, pain, pain-killers consumption, general complications, costs, operative time and early hernia recurrence. Open PVHR is potentially associated to more wound-related complications, but has the advantages of cost-effectiveness, short operative time and totally extra-peritoneal repair. Laparoscopic PVHR has lower wound-related complications but implies placing the mesh in intra-peritoneal position, requires advanced laparoscopic skills, usually does not allow the closure of the defect, and can lead to excessive pain and pain-killers consumption. Robotic PVHR uses the same laparoscopic access as laparoscopic PVHR, but thanks to the extended range of motion given by the robotic system, allows defect closure, pre-peritoneal placement of the mesh and requires less technical skills.In the present randomized controlled trial, we expect to show that robotic PVHR leads to better wound-related outcomes than open PVHR. The present randomized controlled trial was registered into clinicaltrials.gov under registration number NCT04171921.

Sections du résumé

BACKGROUND BACKGROUND
The objective of the present study is to compare the outcomes open PVHR and robotic PVHR.
METHODS/DESIGN METHODS
The present study will be a randomized single-blinded controlled trial with intention-to-treat analysis comparing robotic PVHR to open PVHR in adult patients undergoing elective PVHR with a defect ranging between 1-5 cm. Patient refusing to participate, not able to give informed consent, with history of intra-abdominal surgery contraindicating a robotic surgical approach will be excluded. The intervention will consist in laparoscopic robotically assisted trans-abdominal pre-peritoneal epigastric or umbilical PVHR with closure of fascial defect and non-adsorbable mesh reinforcement. The control will be open pre-peritoneal epigastric or umbilical hernia repair with closure of fascial defect and non-absorbable mesh reinforcement. The primary outcome will be the incidence of wound-related complication within 1 month. The secondary outcomes will be esthetic satisfaction, pain, pain-killers consumption, general complications, costs, operative time and early hernia recurrence.
DISCUSSION CONCLUSIONS
Open PVHR is potentially associated to more wound-related complications, but has the advantages of cost-effectiveness, short operative time and totally extra-peritoneal repair. Laparoscopic PVHR has lower wound-related complications but implies placing the mesh in intra-peritoneal position, requires advanced laparoscopic skills, usually does not allow the closure of the defect, and can lead to excessive pain and pain-killers consumption. Robotic PVHR uses the same laparoscopic access as laparoscopic PVHR, but thanks to the extended range of motion given by the robotic system, allows defect closure, pre-peritoneal placement of the mesh and requires less technical skills.In the present randomized controlled trial, we expect to show that robotic PVHR leads to better wound-related outcomes than open PVHR.
TRIAL REGISTRATION BACKGROUND
The present randomized controlled trial was registered into clinicaltrials.gov under registration number NCT04171921.

Identifiants

pubmed: 32368702
doi: 10.1016/j.isjp.2020.03.004
pii: S2468-3574(20)30011-5
pmc: PMC7186553
doi:

Banques de données

ClinicalTrials.gov
['NCT04171921']

Types de publication

Journal Article

Langues

eng

Pagination

27-31

Informations de copyright

© 2020 The Authors.

Références

Surg Endosc. 2018 Apr;32(4):1901-1905
pubmed: 29411133
J Am Coll Surg. 2015 Aug;221(2):478-85
pubmed: 26206646
Hernia. 2011 Oct;15(5):541-6
pubmed: 21538150
Ann Surg. 2012 Nov;256(5):714-22; discussion 722-3
pubmed: 23095614
Hernia. 2012 Apr;16(2):179-83
pubmed: 21904861
J Gastrointest Surg. 2013 Jan;17(1):159-66; discussion p.166-7
pubmed: 22965649
Br J Surg. 2016 Nov;103(12):1598-1607
pubmed: 27546188
Hernia. 2011 Aug;15(4):463-8
pubmed: 20556448
Hernia. 2017 Dec;21(6):905-916
pubmed: 29032495
Dan Med J. 2016 Jul;63(7):
pubmed: 27399983
Surg Endosc. 2016 Feb;30(2):670-675
pubmed: 26091995
Int J Med Robot. 2015 Jun;11(2):120-5
pubmed: 25236697
JSLS. 2018 Jan-Mar;22(1):
pubmed: 29472756
JAMA Surg. 2013 Nov;148(11):1043-8
pubmed: 24005537
Surg Endosc. 2009 Aug;23(8):1740-4
pubmed: 19015918
J Laparoendosc Adv Surg Tech A. 2018 Apr;28(4):434-438
pubmed: 29293068

Auteurs

Jonathan Douissard (J)

Division of Digestive Surgery, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211 Genève 14, Switzerland.

Jeremy Meyer (J)

Division of Digestive Surgery, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211 Genève 14, Switzerland.

Arnaud Dupuis (A)

Division of Digestive Surgery, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211 Genève 14, Switzerland.

Andrea Peloso (A)

Division of Digestive Surgery, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211 Genève 14, Switzerland.

Julie Mareschal (J)

Division of Digestive Surgery, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211 Genève 14, Switzerland.

Christian Toso (C)

Division of Digestive Surgery, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211 Genève 14, Switzerland.

Monika Hagen (M)

Division of Digestive Surgery, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211 Genève 14, Switzerland.

Classifications MeSH